Nov 08, 2019
1:50
For every 50 shares held, investors received 1.
The split itself did not change the total investment value.
SELLAS Life Sciences Group, Inc. (FRA:RXK3) operates in the Pharmaceuticals: major industry.
SELLAS Life Sciences Group, Inc. company overviewSELLAS Life Sciences Group, Inc.'s most recent stock split was on November 8, 2019. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
SELLAS Life Sciences Group, Inc. (FRA:RXK3) has split its stock 3 times: a 1-for-20 reverse split on November 14, 2016, a 1-for-30 reverse split on January 2, 2018, and a 1-for-50 reverse split on November 8, 2019.
SELLAS Life Sciences Group, Inc. has split its stock 3 times. This history records 3 reverse splits between November 14, 2016 and November 8, 2019.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In SELLAS Life Sciences Group, Inc.'s 1-for-50 reverse split on November 8, 2019, every 50 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
SELLAS Life Sciences Group, Inc. has not announced a new split in our records. Its most recent split was on November 8, 2019, 6 years ago. Companies announce splits in advance, and any new FRA:RXK3 split will appear on this page.